Hypersensitivity to the active ingredient or to other ingredients of the medicinal product.
Concomitant prolactin-dependent tumours (e.g. pituitary gland prolactinomas or breast cancer).
Phaeochromocytoma.
Lactation.
Combination with levodopa.
Children before the onset of puberty.
In combination with the following medicinal products which could induce torsade de pointes: Class Ia antiarrhythmics such as quinidine and disopyramide.
Class III antiarrhythmics such as amiodarone and sotalol.
Other medicinal products such as bepridil, cisapride, sultopride, thioridazine, methadone, erythromycin (intravenous application), vincamine (intravenous application), halofantrine, pentamidine, sparfloxacin, azole antifungals.